BCL7A inhibits the progression and drug-resistance in acute myeloid leukemia
Authors:
- Tushuai LiTLTushuai Li
- Renjie GaoRGRenjie Gao
- Kaiwen XuKXKaiwen Xu
- Pengpeng PanPPPengpeng Pan
- Congcong ChenCCCongcong Chen
- Daokuan WangDWDaokuan Wang
- Keyi ZhangKZKeyi Zhang
- Jilei QiaoJQJilei Qiao
- Yue GuYGYue Gu
Open Access
- 22 July 2024
- journal article
- research article
- Published by Elsevier in Drug Resistance Updates
- Vol. 76
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Acute myeloid leukemia: Therapy resistance and a potential role for tetraspanin membrane scaffoldsThe International Journal of Biochemistry & Cell Biology, 2021
- Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancerComputational and Structural Biotechnology Journal, 2021
- A miR‐194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinomaThe Journal of Pathology, 2019
- Epidemiology of acute myeloid leukemia: Recent progress and enduring challengesBlood Reviews, 2019
- Targeting an RNA-Binding Protein Network in Acute Myeloid LeukemiaCancer Cell, 2019
- Acute myeloid leukaemiaThe Lancet, 2018
- Molecular biomarkers in acute myeloid leukemiaBlood Reviews, 2017
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemiaNature, 2014
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escapeNature Medicine, 2012
- IRF7: activation, regulation, modification and functionGenes & Immunity, 2011